Tandem Diabetes Care, Inc.
TNDMNASDAQHealthcare● Active
$18.66
$-0.68(-3.52%)
Market Cap$1.3B
P/E Ratio—
52W High$29.65
52W Low$9.98
Tandem Diabetes Care, Inc. (TNDM) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TNDM · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.01B | $0.94B | $0.75B | $0.80B | $0.70B |
| Cost of Revenue | $0.48B | $0.45B | $0.38B | $0.39B | $0.33B |
| Gross Profit | $0.53B | $0.49B | $0.37B | $0.41B | $0.38B |
| Gross Margin %(computed) | 52.31% | 52.07% | 49.17% | 51.54% | 53.53% |
| Operating Expenses | |||||
| R&D Expenses | $0.17B | $0.20B | $0.25B | $0.17B | $0.09B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.61B | $0.59B | $0.60B | $0.51B | $0.35B |
| Operating Income | ($0.08B) | ($0.10B) | ($0.23B) | ($0.09B) | $0.02B |
| Operating Margin %(computed) | -7.70% | -10.54% | -31.19% | -11.59% | 3.22% |
| Interest Income | $0.01B | $0.02B | $0.02B | $0.01B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | ($0.20B) | ($0.09B) | ($0.22B) | ($0.09B) | $0.02B |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.20B) | ($0.10B) | ($0.22B) | ($0.09B) | $0.02B |
| Net Margin %(computed) | -20.17% | -10.21% | -29.77% | -11.81% | 2.21% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.04 | $-1.47 | $-3.43 | $-1.47 | $0.25 |
| Wtd Avg Shares | 0.07B | 0.07B | 0.06B | 0.06B | 0.06B |
| EBITDA | ($0.17B) | ($0.10B) | ($0.20B) | ($0.07B) | $0.03B |
| EBITDA Margin %(computed) | -17.22% | -10.54% | -26.27% | -9.26% | 4.85% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Tandem Diabetes Care, Inc. data
About Tandem Diabetes Care, Inc. (TNDM) Income Statement
Tandem Diabetes Care, Inc. (TNDM) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, TNDM reported revenue of $1.01B, gross profit of $0.53B (gross margin 52.31%), and net income of ($0.20B) — a net profit margin of -20.17%.
Frequently asked questions
TNDM · 4 questionsTandem Diabetes Care, Inc. (TNDM) reported revenue of $1.01B for 2025, up 7.9% year-over-year.
TNDM revenueTNDM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08